MSIF

MSIF is a business development company (a levered credit fund), so book value and distribution coverage — not P/E — drive the call. The key fact the headline 8.7x P/E buries: stockholders' equity of $739M across 46.0M shares implies NAV of ~$16.07/share, yet the stock trades at $11.52 — roughly a 28% discount to book (0.72x). For a BDC earning a 12.0% ROE with FY2025 net investment income up 15% ($61.8M vs $53.9M in the MD&A) and net assets from operations up 57% to $88.7M, that discount is the thesis. You are buying a portfolio of income-producing loans at ~72 cents on the dollar.

The balance sheet supports leaning in. Liabilities/equity is just 0.87x and long-term debt is $603M — well inside the 2:1 regulatory ceiling BDCs are allowed, leaving real runway to lever the book into new originations and grow NII without an equity raise. Rate risk, the obvious worry as the Fed eases, is heavily muted: the 10-K states 78% of the debt portfolio (at cost) floats but 97% of that is subject to contractual interest-rate floors, and management's own sensitivity table shows a 100bps cut trims NII by only ~$0.06/share. The Series A Notes are fixed for life. So a falling-rate environment nicks earnings modestly rather than gutting them.